Search for a report

GLOBAL VETERINARY VACCINES MARKET FORECAST 2022-2030

  • You are here:
  • Home
  • Downloads
  • GLOBAL VETERINARY VACCINES MARKET FORECAST 2022-2030

GLOBAL VETERINARY VACCINES MARKET FORECAST 2022-2030

The global veterinary vaccines market is expected to reach $13.95 billion by 2030, growing at a CAGR of 7.37% during the forecast period, 2022-2030.

GLOBAL VETERINARY VACCINES MARKET FORECAST 2022-2030

Global Veterinary Vaccines Market by Animal Type (Livestock Animal, Companion Animal, Aquaculture) Market by Product Type (Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vaccines, Subunit Vaccines) Market by Disease Type (Canine Disease, Porcine Disease, Bovine Disease, Poultry Disease, Aquaculture Disease, Other Diseases) by Geography

Request free sample

The global veterinary vaccines market is expected to reach $13.95 billion by 2030, growing at a CAGR of 7.37% during the forecast period, 2022-2030. The base year considered for the study is 2021, and the estimated period is between 2022 and 2030. The market study has also analyzed the impact of COVID-19 on the veterinary vaccines market qualitatively as well as quantitatively.

To learn more about this report, request a free sample copy

Veterinary Vaccines are pharmaceutical products derived scientifically via R&D and clinical studies, especially to protect the animals from common and life-threatening diseases. In most cases, animal vaccination is done as a pro-active measure in order to ensure animal health and safety from viruses.

Veterinary Vaccines Market

Read our latest blog on the Veterinary Vaccines Market

There are many types of veterinary vaccines available in the market, such as inactivated vaccines, conjugate vaccines, DNA vaccines, toxoid vaccines, recombinant vaccines, attenuated vaccines, and subunit vaccines.

Key enablers of the global veterinary vaccines market growth are:

  • Research and development of advanced vaccines
    • The veterinary vaccine market is highly benefitted due to its industry players’ focus and prioritization of R&D. Every innovative, developed, and advanced product (vaccine), therefore, acts as a market growth enabler.
    • For example, Boehringer Ingelheim introduced the first single-dose piglet vaccine for the control of porcine circovirus disease (PCVD), known as Ingelvac CircoFLEX®. Such developments allow the company to stay relevant, active, and ongoing in the market.
    • Also, Zoetis developed Poulvac® Procerta™ HVT ND, a vaccine that helps protect against Marek’s disease and Newcastle disease among poultries.
  • Need of vaccine due to rising animal population and diseases
  • Vaccination drives by government agencies

Key growth restraining factors are:

  • Rules and regulations for the use of vaccines
    • For marketing and selling the vaccines, companies need to have approval and authorization from regulatory bodies.
    • For companies, it gets tougher as there is no standard and universally accepted procedure of approval. Each country/region has its own standard and measuring parameters.
    • Thus, such legalities and technicalities hamper overall industry performance.
  • Lack of skilled veterinarians and awareness among farmers

Veterinary Vaccines market | Top Trends

  • The market players are innovating better and more effective vaccines. The constant need to be ahead of the competition and provide best-in-class products (vaccines) encourages the companies to be at par or above by being innovative. Thus, it helps the overall industry to grow.
  • The demand for companion animals is growing among the urban population. Most common pets, such as cats and dogs, are in huge demand since humans treat pets as family members. Some adopt them for emotional support and similar purposes, and for some, they are a fashion, fad, or status symbol. Also, pets face health issues, thereby increasing the demand for healthcare and solutions in the form of veterinary vaccines.
  • Several companies and research institutes are looking for ways to provide more efficient vaccines and better solutions. For example, some companies are finding ways to make heat-resistant vaccines that will help to reduce storage costs, whereby companies have to maintain large deposits in cold storage warehouses.

Market Segmentation Analysis – Animal Type, Product Type, and Disease Type –

 Market by Animal Type:

  • Livestock Animal
    • Livestock animal is the dominating segment in the global market by animal type. It entails farm animals used for the purpose of milk and meat production. This animal type is a key category as vaccination of farm animals is necessary in order to maintain global agricultural as well as consumer needs.
      • Cattle
      • Pigs
      • Poultry
      • Sheep
      • Other Livestock Animals
    • Companion Animal
      • Canine
      • Feline
      • Equine
    • Aquaculture

Market by Product Type:

  • Attenuated Vaccines
    • Attenuated vaccines are the largest revenue-generating product type.
    • Live attenuated vaccines (LAV) are formed using pathogens (virus or bacteria) that are the prominent root cause of disease and are weakened under laboratory conditions. As a result, these vaccines are similar to natural infection and help prevent disease by creating a strong and long-lasting immune response.
    • For example, Virbac SA’s CANIGEN® DHPPi/L is a live, modified vaccine that aid in protecting dogs against terminal diseases.
    • Nobivac® DHPPi is a live attenuated vaccine by Merck Animal Health to immunize dogs against canine parvovirus, canine adenovirus, canine distemper virus, and canine parainfluenza virus.
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Subunit Vaccines

Market by Disease Type:

  • Canine Disease
  • Porcine Disease
  • Bovine Disease
  • Poultry Disease
  • Aquaculture Disease
  • Other Diseases

Geographical Study based on Four Major Regions:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Russia, Belgium, Poland, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
    • The Asia-Pacific veterinary vaccines market is anticipated to be the fastest-growing market globally.
    • China and India are the leading countries in major sectors such as livestock animals, including cattle and swine, and are also prominent contributors of fish globally.
    • Additionally, the World Organization for Animal Health (OIE) and the Association of Southeast Asian Nations (ASEAN) signed a new Memorandum of Understanding (MOU) in May 2021 to strengthen their cooperation and further support the control, prevention, and eradication of animal diseases in South-East Asia.
  • Rest of World: Latin America, Middle East & Africa

The major players in the global veterinary vaccines market are:

  • Zoetis Inc
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Merck Animal Health
  • Phibro Animal Health Corp
  • Virbac SA

Key strategies adopted by some of these companies:

In April 2021, Zoetis entered into an agreement to acquire Jurox. Jurox is a privately held animal healthcare company. It is involved in developing, manufacturing, and marketing veterinary medicines for the treatment of companion animals and livestock. It operates in Australia, New Zealand, the US, Canada, and the UK. It provides future growth opportunities, manufacturing capacities, and increased capabilities for Zoetis in the animal healthcare market in Australia.

In September 2020, Vaxxinova purchased Newport Laboratories, a company that manufactures custom-made vaccines for swine and cattle, from Boehringer Ingelheim. Vaxxinova plans to explore and capitalize custom-made vaccines business for cattle and swine segment, which is the specialty of Newport Labs.

Report Synopsis

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue (Million)
Segments Analyzed Product Type, Animal Type, Disease Type
Countries Analyzed North America, Europe, Asia-Pacific, and Rest of World
Companies Analyzed

Boehringer Ingelheim International GmbH, Brilliant Bio Pharma, Ceva Sante Animale, Elanco Animal Health, Hester Biosciences Ltd, Hipra, Indian Immunologicals Limited, Merck Animal Health, Phibro Animal Health, Vaxxinova GmbH, Virbac SA, and Zoetis

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • RESEARCH & DEVELOPMENT OF ADVANCED VACCINES
      • NEED OF VACCINE DUE TO RISING ANIMAL POPULATION AND DISEASES
      • VACCINATION DRIVES BY GOVERNMENT AGENCIES
    • KEY RESTRAINTS
      • RULES & REGULATIONS FOR THE USE OF VACCINE
      • LACK OF AWARENESS AMONG FARMERS AND REQUIREMENT OF SKILLED VETERINARIANS
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON VETERINARY VACCINES MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • REGULATORY FRAMEWORK
  2. MARKET BY ANIMAL TYPE
    • LIVESTOCK ANIMAL
      • CATTLE
      • PIGS
      • POULTRY
      • SHEEP
      • OTHER LIVESTOCK ANIMALS
    • COMPANION ANIMAL
      • CANINE
      • FELINE
      • EQUINE
    • AQUACULTURE
  3. MARKET BY PRODUCT TYPE
    • ATTENUATED VACCINES
    • INACTIVATED VACCINES
    • TOXOID VACCINES
    • CONJUGATE VACCINES
    • DNA VACCINES
    • RECOMBINANT VACCINES
    • SUBUNIT VACCINES
  4. MARKET BY DISEASE TYPE
    • CANINE DISEASE
    • PORCINE DISEASE
    • BOVINE DISEASE
    • POULTRY DISEASE
    • AQUACULTURE DISEASE
    • OTHER DISEASES
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS & DIVESTITURES
    • COMPANY PROFILES
      • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • BRILLIANT BIO PHARMA
      • CEVA SANTE ANIMALE
      • ELANCO ANIMAL HEALTH
      • HESTER BIOSCIENCES LTD
      • HIPRA
      • INDIAN IMMUNOLOGICALS LIMITED
      • MERCK ANIMAL HEALTH
      • PHIBRO ANIMAL HEALTH
      • VAXXINOVA GMBH
      • VIRBAC SA
      • ZOETIS

LIST OF TABLES  

TABLE 1:  MARKET SNAPSHOT – VETERINARY VACCINES

TABLE 2:  REGULATORY FRAMEWORK

TABLE 3:  GLOBAL VETERINARY VACCINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 4:  GLOBAL VETERINARY VACCINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 5:  GLOBAL LIVESTOCK ANIMAL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6:  GLOBAL LIVESTOCK ANIMAL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7:  GLOBAL VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8:  GLOBAL VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9:  GLOBAL CATTLE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10:  GLOBAL CATTLE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11:  GLOBAL PIGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12:  GLOBAL PIGS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13:  GLOBAL POULTRY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14:  GLOBAL POULTRY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15:  GLOBAL SHEEP MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 16:  GLOBAL SHEEP MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 17:  GLOBAL OTHER LIVESTOCK ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 18:  GLOBAL OTHER LIVESTOCK ANIMAL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 19:  GLOBAL COMPANION ANIMAL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 20:  GLOBAL COMPANION ANIMAL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 21:  GLOBAL VETERINARY VACCINES MARKET, BY COMPANION ANIMAL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 22:  GLOBAL VETERINARY VACCINES MARKET, BY COMPANION ANIMAL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 23:  GLOBAL CANINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 24:  GLOBAL CANINE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 25:  GLOBAL FELINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 26:  GLOBAL FELINE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 27:  GLOBAL EQUINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 28:  GLOBAL EQUINE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 29:  GLOBAL AQUACULTURE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 30:  GLOBAL AQUACULTURE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 31:  GLOBAL VETERINARY VACCINES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 32:  GLOBAL VETERINARY VACCINES MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 33:  GLOBAL ATTENUATED VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 34:  GLOBAL ATTENUATED VACCINES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 35:  GLOBAL INACTIVATED VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 36:  GLOBAL INACTIVATED VACCINES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 37:  GLOBAL TOXOID VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 38:  GLOBAL TOXOID VACCINES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 39:  GLOBAL CONJUGATE VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 40:  GLOBAL CONJUGATE VACCINES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 41:  GLOBAL DNA VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 42:  GLOBAL DNA VACCINES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 43:  GLOBAL RECOMBINANT VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 44:  GLOBAL RECOMBINANT VACCINES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 45:  GLOBAL SUBUNIT VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 46:  GLOBAL SUBUNIT VACCINES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 47:  GLOBAL VETERINARY VACCINES MARKET, BY DISEASE TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 48:  GLOBAL VETERINARY VACCINES MARKET, BY DISEASE TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 49:  GLOBAL CANINE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 50:  GLOBAL CANINE DISEASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 51:  GLOBAL PORCINE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 52:  GLOBAL PORCINE DISEASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 53:  GLOBAL BOVINE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 54:  GLOBAL BOVINE DISEASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 55:  GLOBAL POULTRY DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 56:  GLOBAL POULTRY DISEASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 57:  GLOBAL AQUACULTURE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 58:  GLOBAL AQUACULTURE DISEASE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 59:  GLOBAL OTHER DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 60:  GLOBAL OTHER DISEASES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 61:  GLOBAL VETERINARY VACCINES MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 62:  GLOBAL VETERINARY VACCINES MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 63:  NORTH AMERICA VETERINARY VACCINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 64:  NORTH AMERICA VETERINARY VACCINES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 65:  LEADING PLAYERS OPERATING IN NORTH AMERICA VETERINARY VACCINES MARKET

TABLE 66:  EUROPE VETERINARY VACCINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 67:  EUROPE VETERINARY VACCINES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 68:  LEADING PLAYERS OPERATING IN EUROPE VETERINARY VACCINES MARKET

TABLE 69:  ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 70:  ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 71:  LEADING PLAYERS OPERATING IN ASIA-PACIFIC VETERINARY VACCINES MARKET

TABLE 72:  REST OF WORLD VETERINARY VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 73:  REST OF WORLD VETERINARY VACCINES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 74:  LEADING PLAYERS OPERATING IN REST OF WORLD VETERINARY VACCINES MARKET

TABLE 75:  LIST OF MERGERS & ACQUISITIONS

TABLE 76:  LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 77:  LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 78:  LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: VALUE CHAIN ANALYSIS

FIGURE 4: KEY BUYING CRITERIA

FIGURE 5: GLOBAL VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY ANIMAL TYPE, IN 2021

FIGURE 6: GLOBAL VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, 2022-2030 (IN $ MILLION)

FIGURE 7: GLOBAL VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY LIVESTOCK ANIMAL, IN 2021

FIGURE 8: GLOBAL VETERINARY VACCINES MARKET, BY CATTLE, 2022-2030 (IN $ MILLION)

FIGURE 9: GLOBAL VETERINARY VACCINES MARKET, BY PIGS, 2022-2030 (IN $ MILLION)

FIGURE 10: GLOBAL VETERINARY VACCINES MARKET, BY POULTRY, 2022-2030 (IN $ MILLION)

FIGURE 11: GLOBAL VETERINARY VACCINES MARKET, BY SHEEP, 2022-2030 (IN $ MILLION)

FIGURE 12: GLOBAL VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS, 2022-2030 (IN $ MILLION)

FIGURE 13: GLOBAL VETERINARY VACCINES MARKET, BY COMPANION ANIMAL, 2022-2030 (IN $ MILLION)

FIGURE 14: GLOBAL VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY COMPANION ANIMAL TYPE, IN 2021

FIGURE 15: GLOBAL VETERINARY VACCINES MARKET, BY CANINE, 2022-2030 (IN $ MILLION)

FIGURE 16: GLOBAL VETERINARY VACCINES MARKET, BY FELINE, 2022-2030 (IN $ MILLION)

FIGURE 17: GLOBAL VETERINARY VACCINES MARKET, BY EQUINE, 2022-2030 (IN $ MILLION)

FIGURE 18: GLOBAL VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2030 (IN $ MILLION)

FIGURE 19: GLOBAL VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021

FIGURE 20: GLOBAL VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 21: GLOBAL VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 22: GLOBAL VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 23: GLOBAL VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 24: GLOBAL VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 25: GLOBAL VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 26: GLOBAL VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 27: GLOBAL VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY DISEASE TYPE, IN 2021

FIGURE 28: GLOBAL VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2030 (IN $ MILLION)

FIGURE 29: GLOBAL VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2030 (IN $ MILLION)

FIGURE 30: GLOBAL VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2030 (IN $ MILLION)

FIGURE 31: GLOBAL VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2030 (IN $ MILLION)

FIGURE 32: GLOBAL VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2030 (IN $ MILLION)

FIGURE 33: GLOBAL VETERINARY VACCINES MARKET, BY OTHER DISEASES, 2022-2030 (IN $ MILLION)

FIGURE 34: NORTH AMERICA VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 35: UNITED STATES VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 36: CANADA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 37: EUROPE VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 38: UNITED KINGDOM VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 39: GERMANY VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 40: FRANCE VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 41: ITALY VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: RUSSIA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: BELGIUM VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 44: POLAND VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: REST OF EUROPE VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 46: ASIA-PACIFIC VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 47: CHINA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 48: JAPAN VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 49: INDIA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 50: SOUTH KOREA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 51: INDONESIA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 52: THAILAND VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 53: VIETNAM VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 54: AUSTRALIA & NEW ZEALAND VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 55: REST OF ASIA-PACIFIC VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 56: REST OF WORLD VETERINARY VACCINES MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 57: LATIN AMERICA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 58: MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

  1. MARKET BY ANIMAL TYPE
    • LIVESTOCK ANIMAL
      • CATTLE
      • PIGS
      • POULTRY
      • SHEEP
      • OTHER LIVESTOCK ANIMALS
    • COMPANION ANIMAL
      • CANINE
      • FELINE
      • EQUINE
    • AQUACULTURE
  2. MARKET BY PRODUCT TYPE
    • ATTENUATED VACCINES
    • INACTIVATED VACCINES
    • TOXOID VACCINES
    • CONJUGATE VACCINES
    • DNA VACCINES
    • RECOMBINANT VACCINES
    • SUBUNIT VACCINES
  3. MARKET BY DISEASE TYPE
    • CANINE DISEASE
    • PORCINE DISEASE
    • BOVINE DISEASE
    • POULTRY DISEASE
    • AQUACULTURE DISEASE
    • OTHER DISEASES
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Frequently Asked Questions & Answers (FAQs):

    What is the value of the global veterinary vaccines market?

    As of 2021, the global veterinary vaccines market was valued at $7.10 billion.

    Does this report include the COVID-19 impact?

    Yes, the market study has also analyzed the impact of COVID-19 on the veterinary vaccines market qualitatively as well as quantitatively.

    Which is the fastest-growing region in the global veterinary vaccines market?

    Asia-Pacific is the fastest-growing region in the global veterinary vaccines market.

    Which is the fastest-growing product type in the global veterinary vaccines market?

    DNA Vaccines are the fastest-growing product type in the market, with a CAGR of 10.22%.

    To request a free sample copy of this report, please complete the form below:

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now